Diagnosis and treatment of nephrotic syndrome

Bibliography

• RAINE AE: The rising tide of diabetic nephropathy-the warning before the flood. Neph. Dial. Transp. (1995) 10:460–461.
   PubMed Web of Science ®Google Scholar
• DANIELS BS: The natural history of renal disease in diabetes mellitus. In: The Principles and Practice of Nephrology. Jacobsen HR, Striker GE, Klahr S (Eds.), Mosby, St. Louis, USA (1995):336–339.
   Google Scholar
• SCHWARTZ MM, KORBET SM: Amyloidosis and the dysproteinemias. In: Immunologic Renal Diseases. Neilson EG, Couser WG (Eds.) Lippincott-Raven, Philadel-phia, USA (1997):1147–1160.
   Google Scholar
• ALPERS CE: Immunotactoid (microtubular) glomerulo-pathy: an entity distinct from flbrillary glomeru-lonephritis? Am. J. Kid. Dis. (1992) 19:185–191.
   PubMedGoogle Scholar
• KORBET SM, SCHWARTZ MM, LEWIS EJ: Immunotactoid glomerulopathy. Am J. Kid. Dis. (1991) 27:247–257.
   Google Scholar
• KORBET SM, SCHWARTZ MM, LEWIS EJ: The flbrillary glomerulopathies. Am. J. Kid. Dis. (1994) 23:751–765.
   PubMed Web of Science ®Google Scholar
• GERTZ MA, KYLE RA: Prognostic value of urinary protein in primary systemic amyloidosis (AL). Am. J. Clin. Pathol. (1990) 94:313–317.
   PubMed Web of Science ®Google Scholar
• GERTZ MA, KYLE RA, GREIPP PR: Amyloidosis (Al): clinical and laboratory features in 229 cases. Mayo. Clin. Proc. (1983) 58:665–683.
   PubMed Web of Science ®Google Scholar
• KORBET SM, SCHWARTZ MM, LEWIS EJ: The flbrillary glomerulonephropathies. Am. J. Kidney Dis. (1994) 23:751–765.
   PubMed Web of Science ®Google Scholar
• KORBET SM, ROSENBERG BF, SCHWARTZ MM et al: Course of renal transplantation in immunotactoid glomerulopathy. Am. J. Med. (1990) 89:91–95.
   PubMed Web of Science ®Google Scholar
• KIMMEL P: Clinical and immunopathogenic aspects of human immunodeficiency virus associated renal diseases. In: Immunologic Renal Diseases. Neilson EG, Couser WG (Eds.), Lippincott-Raven, Philadelphia, USA (1997):1181–1197.
   Google Scholar
• HARRINGTON JT: Collapsing glomerulopathy; clinico-pathologic conference. Hellenic Neph. (1996) 8:161–170.
   Google Scholar
• BLOOM RD, WEISS R, MADAIO MP: The nephritogenic immune response. In: Current Nephrology. Gonick, HC (Ed.) (1993):441–448.
   Google Scholar
• JOHNSON RJ, GRETCH DR, COUSER WG et al.: Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int. (1994) 46:1700–1704.
   PubMed Web of Science ®Google Scholar
• •Transient benefit of y IFN in hepatitis C glomerulonephritis.
   Google Scholar
• HABATE B: Acute renal failure due to falciparum malaria. Renal Failure (1990) 12:15–19.
   PubMed Web of Science ®Google Scholar
• JOHNSON RJ, KIMMEL PL: Glomerular diseases associ-ated with viral and parasitic infections In: The Principles and Practice of Nephrology. Jacobsen HR, Striker GE, Klahr S (Eds.), Mosby, St. Louis, USA (1995):128–132.
   Google Scholar
• MADAIO MP: Postinfectious glomerulonephritis. In: The Principles and Practice of Nephrology. Jacobsen HR, Striker GE, Klahr S (Eds.), Mosby, St. Louis, USA (1995):122–127.
   Google Scholar
• KASINATH BS: Proteinuria. In: Internal Medicine. Stein J. (Ed.) Mosby, St. Louis, USA (1997):758–761.
   Google Scholar
• ALPERS CE, COTRAN RS: Neoplasia and glomerular injury. Kidney Int. (1986) 30:465.
   PubMed Web of Science ®Google Scholar
• ••Excellent review, well referenced.
   Google Scholar
• RAULT R, HOLLEY JL, BANNER BF et al.: Glomeru-lonephritis and non-Hodgkin's lymphoma: A report of two cases and review of the literature. Am. J. Kidney. Dis. (1992) 20:84.
   PubMed Web of Science ®Google Scholar
• CLIVE DM, STOFF JS: Renal Syndromes associated with non-steroidal anti-inflammatory drugs. New Engl. J. Med. (1984) 310:563.
   PubMed Web of Science ®Google Scholar
• KOENIG KG, BOLTON WK: Clinical evaluation and treatment of hematuria and proteinuria. In: Immuno-logic Renal Diseases. Neilson EG, Couser WG (Eds.), Lippincott-Raven, Philadelphia, USA (1997):805–836.
   Google Scholar
• CAMERON JS: Systemic lupus erythematosus. In: Immunologic Renal Diseases. Neilson EG, Couser WG (Eds.), Lippincott-Raven, Philadelphia, USA (1997):1055–1098.
   Google Scholar
• BOUMPAS DT, AUSTIN HA, VAUGHN EM et al.: Controlled trial of pulse methyleprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. (1992) 340:741–45.
   PubMed Web of Science ®Google Scholar
• LEWIS EJ, HUNSICKER MD, LAN SP et al.: A controlled trial of plasmapheresis in severe lupus nephritis. New Engl. J. Med (1992) 326:1973–1979.
   Google Scholar
• •Failure of plasmapheresis to improve outcome in severe lupus nephritis.
   Google Scholar
• BALOW JE, BOUMPAS DT, FESSLER BJ et al: Management of lupus nephritis. Kidney Int. (1996) 49\(Suppl. 53):S88–S92.
   Google Scholar
• HASS M, MEEHAN S, KARRISON TG et al.: Changing etiologies of unexplained adult nephrotic syndrome: A comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am. J. Kid. Dis. (1997) 30:621–631.
   PubMed Web of Science ®Google Scholar
• ••Excellent update on the aetiology of nephrotic syndrome inthe 1990s.
   Google Scholar
• GLASSOCK RJ, COHEN AH, ADLER SG et al.: Secondary Glomerular Diseases. In: The Kidney Brenner BM, Rector FC (Eds.), WB Saunders, Philadelphia, USA (1990:1280–1368.
   Google Scholar
• COUSER WG, ALPERS CE: Membranous nephropathy. In: Immunologic Renal Diseases. Neilson EG, Couser WG (Eds.), Lippincott-Raven, Philadelphia, USA (1997):1027–1055.
   Google Scholar
• SCHIEPPATI A, MOSCONI L, PERNA A et al.: Prognosis of untreated patients with idiopathic membranous nephropathy. New Engl. J. Med. (1993) 329:85.
   PubMed Web of Science ®Google Scholar
• PONTICELLI C, ZUCCHELLI P, PASSERINI P et al.: A randomized trial of methylprednisolone and chloram-bucil in idiopathic membranous nephropathy. New Engl. J. Med. (1989) 320:8.
   PubMed Web of Science ®Google Scholar
• PONTICELLI C, ZUCCHELLI P, PASSERINI P et al.: A 10-year follow up of a randomized study with methyl-prednisolone and chlorambucil in membranous nephropathy. Kidney Int. (1995) 48:1600.
   PubMed Web of Science ®Google Scholar
• PONTICELLI C, ALTIERI P, SCOLARI F et al: A randomized study comparing methyleprednisolone plus chloram-bucil versus methylprednisolone plus cyclophospha-mide in idiopathic membranous nephropathy. J. Am. Soc. Nephrol (1998) 9:444.
   PubMed Web of Science ®Google Scholar
• PONTICELLI C: Prognosis and treatment of membra-nous nephropathy. Kidney Int. (1986) 29:927–940.
   PubMed Web of Science ®Google Scholar
• •References 30–34 describe the Italian experience in treating membranous nephropathy with steroids and chlorambucil.
   Google Scholar
• CAMERON JS, CHANTLER C, OGG CS et al.: Long-term stability of remission in nephrotic syndrome after treatment with cyclophosphamide. BMJ (1974) 4:7.
   PubMed Web of Science ®Google Scholar
• ARBEITSGEMEINSCHAFT FUR PADIATRISCHE NEPHROLOGIE: Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependance. New Engl. J. Med. (1982) 306:451.
   PubMedGoogle Scholar
• PONTICELLI C, EDEFONTI A, GHIO L et al.: Cyclosporin versus cyclophosphamide for patients with steroid-dependant and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol. Dial. Transplant. (1993) 8:1326.
   PubMed Web of Science ®Google Scholar
• ITTEL TH, CLASEN W, FUHS M et al.: Long-term cyclosporine A treatment in adults with minimal change nephrotic syndrome or focal segmental glomerulosclerosis. Clin. Nephrol. (1995) 44:156.
   PubMed Web of Science ®Google Scholar
• D'AGATI V, SUH JI, CARBONE L et al.: Pathology of HIV-associated nephropathy: A detailed morpologic and comparative study. Kidney Int. (1989) 35:1358.
   Google Scholar
• ••Benchmark description of HIV nephropathy.
   Google Scholar
• SCHNAPPER HVV: Focal segmental glomerulosclerosis. In: Immunologic Renal Diseases. Neilson EG, Couser WG (Eds.), Lippincott-Raven, Philadelphia, USA (1997):1003–1027.
   Google Scholar
• INGULLI E, SINGH A, BAQI N et al.: Agressive long term cyclosporine therapy for steroid resistant focal segmental glomerulosclerosis. J. Am. Soc. Neph. (1995) 5:1820–1825.
   PubMed Web of Science ®Google Scholar
• MENDOZA S, REZNIK V, GRISWOLD W et al.: Treatment of steroid resistant focal segmental glomeruloscle-rosis with methylprednisolone and alkylating agents. Pediatr. Nephrol. (1990) 4:303–307.
   PubMed Web of Science ®Google Scholar
• RIVKEES SA, CRAWFORD JD: The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA (1988) 259:2123–2125.
   PubMed Web of Science ®Google Scholar
• DONADIO JV, BERGSTRALH EJ, OFFORD KP et al: A controlled trial of fish oil therapy in IgA nephropathy. New Engl. J. Med. (1994) 331:1194–1199.
   PubMed Web of Science ®Google Scholar
• BENNETT WM, WALKER RG, KINCAID-SMITH WP: Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two year prospective trial. Clin. Nephrol. (1989) 31:128–131.
   PubMed Web of Science ®Google Scholar
• PETTERSSON EE, REKOLA S, BERGLUND L et al.: Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acid a prospective, double-blind, randomized study. Clin. Nephrol 41:183–190.
   Google Scholar
• •References 44–46 include opposing data on the potential benefit of fish oil therapy in the treatment of IgA nephropathy.
   Google Scholar
• KAYSEN GA, GAMBERTOGLIO J, JIMENEZ I etal.: Effect of dietary protein on albumin homeostasis in nephrotic patients. Kidney Int. (1986) 29:572–577.
   Google Scholar
• KAYSEN GA, JONES H, MARTIN V et al.: Low protein diet restricts protein synthesis in nephrotic rats. J. Clin. Invest. (1989) 83:1623–1629.
   PubMed Web of Science ®Google Scholar
• APARAICIO M., BOUCHET JL, GIN H et al.: Effect of a low-protein diet on urinary albumin excretion in uremic patients. Nephron (1988) 50:288–291.
   Google Scholar
• GUARNARIERI GF et al.: Nutritional status in patients on a long-term low protein diet or with nephrotic syndrome. Kidney Int. (1989) 36 (Supp1.27): S195–5200.
   Google Scholar
• ••Provides caution with regard to low protein diet in nephroticpatients.
   Google Scholar
• WARWICK GL, PACKARD CJ: Pathogenesis of lipid abnormalities in patiens with nephrotic syndrome/proteinuria: Clinical Implications. Miner. Elec. Metab. (1993) 19:115.
   PubMedGoogle Scholar
• WARWICK GL, PACKARD CJ: Lipoprotein metabolism inthe nephrotic syndrome. Nephrol. Dial. Transpl. (1993) 8:385–396.
   PubMed Web of Science ®Google Scholar
• KEANE WF, ST PETER JV, KASISKE BL: Is the aggressive management of hyperlipidemia in nephrotic patients mandatory? Kidney Int. (1992) 42 (Supp1.38):S134–S141.
   Google Scholar
• ORDONEZ JD, HIATT RA, KILLEBREW et al.: The increased risk of coronary heart disease associated with nephrotic syndrome. Kidney Int. (1993) 44:638.
   PubMed Web of Science ®Google Scholar
• D'AMICO G, GENTILE MG: Influence of diet on lipid abnormalities in human renal disease. Am. J. Kid. Dis. (1993) 22:151.
   PubMed Web of Science ®Google Scholar
• LAGRUE G, ROBEVA R, LAURENT J: Antiproteinuric effect of captopril in primary glomerular disease. Nephron (1987) 46:99–100.
   PubMedGoogle Scholar
• •Provides rational for ACE inhibition in lowering protein excretion in nephrotic syndrome.
   Google Scholar
• MEYER TW, MORELLI E, LOON N et al.: Converting enzyme inhibition and glomerular size selectivity in diabetic nephropathy. J. Am. Soc. Nephrol. (1990) 1:S64.
   PubMed Web of Science ®Google Scholar
• BRUNNER HR: ACE inhibitors in renal disease. Kidney Int. (1992) 42:463.
   PubMed Web of Science ®Google Scholar
• HEEG JE, DE JONG PE, VAN DER HEM GK et al.: Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril. Kidney Int (1989) 272:36.
   Google Scholar
• PERICO N, REMUZZI A, SANGALLI F et al.: The antiprote-inuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin. J Am. Soc. Nephrol (1998) 9:2308–2317.
   PubMed Web of Science ®Google Scholar
• •Antiproteinuric effect with indomethicin in combination with an ACE inhibitor and an angiotension II receptor blocker.
   Google Scholar
• GANSEVOORT RT, DE ZEEUVV D, DE JONG PE: Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Kidney Int. (1994) 45:861–867.
   Google Scholar
• ALLON M, PASQUE CB, RODRIGUEZ M: Acute effects of captopril and ibuprofen on proteinuria in patients with nephrosis J. Lab. Clin. Med. (1990) 116:462–468.
   PubMedGoogle Scholar
• HEEG JE, DE LONG PE, VRIESENDORP R et al.: Additive antiproteinuric effect of the NSAID indomethacin and the ACE inhibitor lisinopril. Am. J. Nephrol. (1990) 10\(Suppl. 1):94–97.
   Google Scholar
• PERICO N, REMUZZI G: Renal handling of sodium in the nephrotic syndrome. Am. J. Nephrol (1993) 13:413–421.
   PubMed Web of Science ®Google Scholar
• •Describes the effects on sodium in the nephrotic syndrome.
   Google Scholar
• KELLER E, HOPPE-SEYLER G, SCHOLLMEYER P: Disposi-tion and diuretic effect of furosemide in the nephrotic syndrome. Clin. Pharmacol. (1982) 32:442–449.
   Google Scholar
• ELLISON DH: The physiological basis of diuretic synergism: Its role in treating diuretic resistance. Ann. Intern. Med. (1991) 114:886–894.
   PubMed Web of Science ®Google Scholar
• ••Explains rationale and approach for use of multiple diureticsin resistant patients.
   Google Scholar
• FLISER D, ZURBRUGGEN I, MUTSCHLER E et al.:Coadministration of albumin and furosemide in patients with nephrotic syndrome. Kidney Int. (1999) 55:629–634.
   PubMed Web of Science ®Google Scholar
• GOLDSTEIN DA, HALDIMAN B, SHERMAN D et al.: Vitamin D metabolites and calcium metabolism in patients with nephrotic syndrome and normal renal function. J. Clin. Endocrinol. Metabol. (1981) 52:116–121.
   PubMed Web of Science ®Google Scholar
• ALON U, CHAN JCM: Calcium and vitamin D homeostasis in the nephrotic syndrome: Current status. Nephron (1984) 36:1.
   PubMedGoogle Scholar
• LLACH F: Hypercoagulability, renal vein thrombosis and other thrombotic complications of nephrotic syndrome. Kidney Int. (1985) 28:429.
   PubMed Web of Science ®Google Scholar
• •Comprehensive discussion of hypercoagulability and nephrotic syndrome.
   Google Scholar
• CAMERON JS: Coagulation and thromboembolic complications in the nephrotic syndrome. Adv. Nephrol. (1984) 13:75.
   PubMedGoogle Scholar
• SARASIN FP, SCHIFFERLI JA: Prophylacitic oral antico- agulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int. (1994) 45:478.
   Google Scholar
• •Discusses the risks and benefits of instituting anticoagula-tion in patients with membranous nephropathy.
   Google Scholar
• HULL RD, RASKOB GE, PINEO GF et al.: A comparison of subcutaneous low molecular weight heparin compared with warfarin for prophylaxis against deep-vein thrombosis after hip or knee implantation. New Engl J. Med. (1993) 329:1370.
   PubMed Web of Science ®Google Scholar